taxonomy (2)
protein (28)
source (3)
structure (0)
composition (1)
disease (3)
reference (3)
site (40)
peptide (45)
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Alpha-galactosidase A / Homo sapiens P06280
- Bone marrow stromal antigen 2 / Homo sapiens Q10589
- Cation-independent mannose-6-phosphate receptor / Homo sapiens P11717
- CD276 antigen / Homo sapiens Q5ZPR3
- CD44 antigen / Homo sapiens P16070
- CD59 glycoprotein / Homo sapiens P13987
- Clusterin / Homo sapiens P10909
- Fibromodulin / Homo sapiens Q06828
- Gamma-glutamyltranspeptidase 1 / Homo sapiens P19440
- Hemopexin / Homo sapiens P02790
- HLA class II histocompatibility antigen, DRB1-1 beta chain / Homo sapiens P04229
- HLA class II histocompatibility antigen, DRB1-10 beta chain / Homo sapiens Q30167
- HLA class II histocompatibility antigen, DRB1-9 beta chain / Homo sapiens Q9TQE0
- Integrin alpha-2 / Homo sapiens P17301
- Integrin beta-1 / Homo sapiens P05556
- Kininogen-1 / Homo sapiens P01042
- Laminin subunit gamma-1 / Homo sapiens P11047
- Lumican / Homo sapiens P51884
- Lysosomal acid phosphatase / Homo sapiens P11117
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Mammaglobin-A / Homo sapiens Q13296
- Membrane cofactor protein / Homo sapiens P15529
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Transmembrane protein 87A / Homo sapiens Q8NBN3
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
Reported structure
- Hex:8 HexNAc:7 NeuAc:1 (avg mass : 3028.7774 )
Composition
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Bone marrow stromal antigen 2 / Homo sapiens
- Cation-independent mannose-6-phosphate receptor / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Clusterin / Homo sapiens
- Fibromodulin / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Hemopexin / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-1 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-10 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-9 beta chain / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Lumican / Homo sapiens
- Lysosomal acid phosphatase / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mammaglobin-A / Homo sapiens
- Membrane cofactor protein / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Transmembrane protein 87A / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- FECHFFNGTER (11aa)
- FECHFFNGTER (11aa)
- FECHFFNGTER (11aa)
- WQMNFTVR (8aa)
- ELLQEFIDDNATTNAIDELK (20aa)
- AFNSTLPTMAQMEK (14aa)
- YETTNK (6aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DVVTAAGDMIKDNATEEEIIVYIEK (25aa)
- GYFYIPPIATHTICDRNHTWIPVSDDACYR (30aa)
- QIVHSFAEGQDQGSAYANR (19aa)
- GFQDVEAQAATCNHTVMAIMASIDAEK (27aa)
- TCDWIPKPNMSASCK (15aa)
- IKEIPGVCNETMMAIWEECKPCIK (24aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- IAFATMFNSSEQSQK (15aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- KLHINHNNLTESVGPLPK (18aa)
- IFQNCSEIFK (10aa)
- FNPNISWQPIPVHTVPITEDR (21aa)
- IGIYADVGNK (10aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- IYIDHNNITR (10aa)
- SWPAVGNCSSALR (13aa)
- ITYSIVQTNCSK (12aa)
- TNSTFVQALVEHVK (14aa)
- LNSSTIK (7aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- FPNITNLCPFGE (12aa)
- IIDNNKTEK (9aa)
- DIENIKDASSFIAEWQNITK (20aa)
- IANITQGEDQYYIR (14aa)
- LANLTQGEDQYYLR (14aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- MSVINFECNK (10aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- KDTCTQECSYFNITK (15aa)
- TASCSNVTCWIK (12aa)
- KIPAINQTITEANEK (15aa)
Mass spectrometry observed peptide
-
- Hex:8 HexNAc:7 NeuAc:1 / N-Linked (avg mass : 3028.7774)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Bone marrow stromal antigen 2 / Homo sapiens
- Cation-independent mannose-6-phosphate receptor / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Clusterin / Homo sapiens
- Fibromodulin / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Hemopexin / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-1 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-10 beta chain / Homo sapiens
- HLA class II histocompatibility antigen, DRB1-9 beta chain / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Lumican / Homo sapiens
- Lysosomal acid phosphatase / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mammaglobin-A / Homo sapiens
- Membrane cofactor protein / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Transmembrane protein 87A / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- FECHFFNGTER (11aa)
- FECHFFNGTER (11aa)
- FECHFFNGTER (11aa)
- WQMNFTVR (8aa)
- ELLQEFIDDNATTNAIDELK (20aa)
- AFNSTLPTMAQMEK (14aa)
- YETTNK (6aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DVVTAAGDMIKDNATEEEIIVYIEK (25aa)
- GYFYIPPIATHTICDRNHTWIPVSDDACYR (30aa)
- QIVHSFAEGQDQGSAYANR (19aa)
- GFQDVEAQAATCNHTVMAIMASIDAEK (27aa)
- TCDWIPKPNMSASCK (15aa)
- IKEIPGVCNETMMAIWEECKPCIK (24aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- IAFATMFNSSEQSQK (15aa)
- TQSLLIVNNATNVVIK (16aa)
- LHINHNNLTESVGPLPK (17aa)
- KLHINHNNLTESVGPLPK (18aa)
- IFQNCSEIFK (10aa)
- FNPNISWQPIPVHTVPITEDR (21aa)
- IGIYADVGNK (10aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- IYIDHNNITR (10aa)
- SWPAVGNCSSALR (13aa)
- ITYSIVQTNCSK (12aa)
- TNSTFVQALVEHVK (14aa)
- LNSSTIK (7aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- FPNITNLCPFGE (12aa)
- IIDNNKTEK (9aa)
- DIENIKDASSFIAEWQNITK (20aa)
- IANITQGEDQYYIR (14aa)
- LANLTQGEDQYYLR (14aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- MSVINFECNK (10aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- KDTCTQECSYFNITK (15aa)
- TASCSNVTCWIK (12aa)
- KIPAINQTITEANEK (15aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
